Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: A Multicentre Pilot Randomized Trial
Taking innovative research from concept to application is critical for improving health care systems and well-being of patients. Vancouver Coastal Health Research Institute (VCHRI) is proud to support investigators and their groundbreaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
The 2025 Innovation and Translational Research Award recipients are:
A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared with Usual Standard of Care on Left Ventricular Mass Index in Participants with Fabry Disease and Left Ventricular Hypertrophy (CARAT)
Research is crucial to improving health outcomes and unlocking the potential of new medication, treatments and medical devices. However, it has historically excluded certain groups, including Indigenous Peoples, leading to biased results that do not accurately reflect the experiences of all Canadians. Expanding research to be more inclusive ensures findings are more representative of the broader population, leading to more impactful outcomes.
A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects with Fabry Disease (MODIFY)
Malnutrition puts older adults at greater risk of hospital readmission from consequential injuries such as falls, fractures and infections, as well as being a risk factor for death. Vancouver Coastal Health Research Institute (VCHRI) researcher Leila Goharian’s research is the first in Canada to describe the prevalence of malnutrition among older adults newly referred to home care services from hospitals in British Columbia.
